Innovision IP at the Adult Brain Injury Conference 2025: advancing neuro-imaging, together

On 12 June 2025 more than 250 clinicians, lawyers and rehabilitation specialists gathered at The Lowry, Salford Quays, for the Adult Brain Injury Conference. Hosted by the Brain Injury Group, the one-day programme shone a spotlight on the latest clinical breakthroughs, legal developments and support pathways for people living with traumatic brain injury (TBI). Innovision IP was honoured to serve as Headline Sponsor, a role that allowed us to help shape the day’s agenda and share our world-leading neuro-imaging technology with delegates.

Why we sponsored

Brain injuries are complex, often invisible, and life-changing. Traditional MRI shows only a fraction of the damage; our proprietary analysis compares each scan against thousands of age- and gender-matched controls to reveal micro-structural abnormalities that would otherwise go undetected. By sponsoring the conference we aimed to:

• champion earlier, more objective diagnosis;

• bridge the gap between cutting-edge science and day-to-day clinical or medico-legal practice;

• foster collaboration across the multidisciplinary brain-injury community.

Innovision CEO Peter Schwabach and Dr Jie Li

Programme highlights

The agenda was packed with experts whose research perfectly aligned with our mission:

• Professor David Menon CBE unpacked new pathways for testing emerging TBI treatments, underlining the need for sensitive imaging biomarkers.

• Dr Steven Allder and Pankaj Madan explored how evolving neuro-imaging techniques are reshaping medico-legal practice—reinforcing the relevance of our own diffusion-weighted and cortical-analysis reports.

• A lively panel led by Dr Keith Jenkins examined the real-world impact of TBI on personal relationships, reminding us that every voxel on a scan represents a human story.

Delegates also heard updates on assistive AI for gait rehabilitation, a Court of Protection case-law review, and the latest NIHR-funded research into family outcomes—underlining the holistic journey from diagnosis to long-term support.

Peter Schwabach with Professor Jian Zhang at the Innovision stall

Innovision IP in action

Throughout the day our team demonstrated how a standard 3 T MRI, processed through Innovision IP’s high-performance pipeline, can:

• visualise white-matter tract disruption via diffusion-weighted imaging;

• quantify myelin loss and cortical-thickness changes in grey matter;

• deliver a medico-legal report within seven working days.

Seeing a “normal” MRI slice transform into a colour-coded map of micro-structural damage stopped many visitors in their tracks; several clinicians remarked that our analysis “puts objective numbers behind the symptoms we hear in clinic.”

Challenge	Session takeaway	Innovision IP perspective
Subtle injuries missed by routine MRI	Need for sensitive biomarkers (Prof Menon, Dr Allder)	Multi-parameter analysis (DWI, myelin, cortical thickness) detects hidden damage
Delayed diagnosis clouds litigation	Capacity to litigate & liability update sessions	Fast, objective reporting strengthens evidential clarity
Family wellbeing often overlooked	Research into post-TBI family outcomes	Imaging is the start; partnerships drive whole-person care

Looking ahead

The conference closed with networking drinks overlooking Salford Quays—an apt setting to reflect on progress and plan future collaborations. For Innovision IP the day reaffirmed a shared commitment: combine next-generation imaging with multidisciplinary expertise so that every person with a brain injury receives the answers, treatment and compensation they deserve.

If you would like to explore collaborative research, arrange a demonstration or discuss a live case, please contact our team at enquiries@innovision-ip.com. We look forward to continuing the conversation—see you at the Child Brain Injury Conference in January 2026!